Mox-Duo: Newest Pain Drug Soon to be On the Market

The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee is scheduled to meet to discuss the safety and efficacy of MoxDuo, a new morphine sulfate and oxycodone hydrochloride combination. Moxduo will be used to treat moderate to severe acute pain where the use of opioid analgesic is appropriate, according to Pain Medicine News.  If MoxDuo is approved, it’ll be the first combination drug to include two immediate-release opioids. 

Listen to whole story on NPR's Morning Edition here

SHARE: 

Facebook
Twitter
LinkedIn
Email

Do you need Substance Abuse Professional Services?

ASAP offers a nationwide network of over 5,000 locations with DOT qualified SAPs. Our trained and knowledgeable team will assist you in understanding the process and signing up. It’s fast and easy to enroll with ASAP! 888.792.2727 x607

Scroll to Top